Literature DB >> 8618195

Transient congenital hypoparathyroidism: resolution and recurrence in chromosome 22q11 deletion.

F Greig1, E Paul, J DiMartino-Nardi, P Saenger.   

Abstract

Transient congenital hypoparathyroidism (TCHP), with spontaneous resolution in infancy and subsequent recurrence in childhood, has not been associated with a specific cause. We report three patients with TCHP, initially with severe but transient neonatal hypocalcemia. During childhood, recurrence of hypoparathyroidism and recognition of phenotypic features suggested a diagnosis of velocardiofacial syndrome (VCFS). Features specific for the DiGeorge syndrome, with known clinical and genetic overlap with VCFS, were not present except for hypoparathyroidism. Genetic analysis confirmed chromosome 22q11 deletion in each patient. TCHP may be the earliest specific finding in 22q11 deletion/VCFS subgroup, with other diagnostic features emerging in later childhood. Infants with resolved TCHP need continued observation of parathyroid sufficiency, genetic analysis, and examination for anomalies associated with chromosome 22q11 deletion.

Entities:  

Mesh:

Year:  1996        PMID: 8618195     DOI: 10.1016/s0022-3476(96)70372-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  11 in total

Review 1.  Genetic Disorders of Parathyroid Development and Function.

Authors:  Rebecca J Gordon; Michael A Levine
Journal:  Endocrinol Metab Clin North Am       Date:  2018-10-12       Impact factor: 4.741

Review 2.  Velocardiofacial syndrome.

Authors:  A C Pike; M Super
Journal:  Postgrad Med J       Date:  1997-12       Impact factor: 2.401

3.  Parathyroid hormone is essential for normal fetal bone formation.

Authors:  Dengshun Miao; Bin He; Andrew C Karaplis; David Goltzman
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

4.  Characteristics of 22q 11.2 deletion syndrome undiagnosed until adulthood: an example suggesting the importance of psychiatric manifestations.

Authors:  Kenta Furuya; Yosuke Sasaki; Taizo Takeuchi; Yoshihisa Urita
Journal:  BMJ Case Rep       Date:  2015-06-08

5.  Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB.

Authors:  C Ding; B Buckingham; M A Levine
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

6.  A novel mutation in the GCM2 gene causing severe congenital isolated hypoparathyroidism.

Authors:  Daniel Doyle; Susan M Kirwin; Katia Sol-Church; Michael A Levine
Journal:  J Pediatr Endocrinol Metab       Date:  2012       Impact factor: 1.634

7.  Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study.

Authors:  A K Ryan; J A Goodship; D I Wilson; N Philip; A Levy; H Seidel; S Schuffenhauer; H Oechsler; B Belohradsky; M Prieur; A Aurias; F L Raymond; J Clayton-Smith; E Hatchwell; C McKeown; F A Beemer; B Dallapiccola; G Novelli; J A Hurst; J Ignatius; A J Green; R M Winter; L Brueton; K Brøndum-Nielsen; P J Scambler
Journal:  J Med Genet       Date:  1997-10       Impact factor: 6.318

8.  A patient with 22q11.2 deletion syndrome: case report.

Authors:  Sema Kabataş Eryılmaz; Firdevs Baş; Ali Satan; Feyza Darendeliler; Rüveyde Bundak; Hülya Günöz; Nurçin Saka
Journal:  J Clin Res Pediatr Endocrinol       Date:  2009-02-06

9.  Endocrine and Growth Disorders in Taiwanese Children With 22q11.2 Deletion Syndrome.

Authors:  Han-Yi Lin; Wen-Yu Tsai; Yi-Ching Tung; Shih-Yao Liu; Ni-Chung Lee; Yin-Hsiu Chien; Wuh-Liang Hwu; Cheng-Ting Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-31       Impact factor: 5.555

10.  A typical 22q11.2 deletion syndrome and pseudohypoparathyroidism: A CARE compliant case report.

Authors:  Xi-Juan Liu; Chen Yan; Jing-Yu Jia
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.